This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Teva Pharmaceutical Industries Limited, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2001-2010.
Company Filing History:
2 out of 505 
1 out of 910 
Years Active: 2001-2010
Title: The Contributions of Inventor Mazal Dahan
Introduction
Mazal Dahan, an innovative inventor based in Jerusalem, Israel, has significantly contributed to the field of pharmaceuticals with his inventive concepts. With three patents to his name, Dahan's work primarily focuses on enhancing the delivery mechanisms of therapeutic agents for various medical conditions.
Latest Patents
Dahan’s latest patents showcase his commitment to improving patient care through pharmaceutical innovation. One of his notable inventions is a rapidly expanding composition designed for gastric retention and controlled release of therapeutic agents. This pharmaceutical composition is intended for oral administration, expanding upon contact with gastric fluids, which allows for extended retention in the patient's stomach. It is particularly beneficial in treating conditions such as Parkinson's disease with levodopa and hyperactivity and attention deficit disorder with methylphenidate.
Another remarkable patent by Dahan involves a composition and dosage form for delayed gastric release of alendronate and other bisphosphonates. This compacted pharmaceutical composition expands upon contact with gastric fluid, ensuring prolonged delivery of the therapeutic bisphosphonate to the stomach. It includes a non-hydrated hydrogel, a superdisintegrant, and tannic acid, providing effective solutions for patient treatment over extended periods.
Career Highlights
Mazal Dahan has enjoyed a distinguished career, collaborating with prominent institutions, including Teva Pharmaceutical Industries Limited and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His research has paved the way for advancements in pharmaceutical formulations, making a significant impact on therapeutic delivery methods.
Collaborations
Throughout his career, Dahan has worked alongside reputed professionals in the field, such as Vered Rosenberger and Moshe Flashner-Barak. These collaborations have fostered a dynamic exchange of ideas and have propelled innovations that enhance patient outcomes.
Conclusion
Mazal Dahan's contributions to the pharmaceutical industry through his innovative patents represent a vital aspect of improving drug delivery systems for various medical conditions. His dedication to research and collaboration with esteemed organizations and professionals continues to pave the way for future advancements in the field, underscoring the importance of innovation in healthcare.